A new clinical trial, testing the drug CBX-12 for metastatic colorectal cancer patients, will soon be enrolling (NCT06730100).
Dr. Kuang is the study chair and the study is being conducted as part of the Experimental Therapeutics Clinical Trial Network, part of the National Cancer Institute.
To learn more about the trial, visit: https://clinicaltrials.gov/study/NCT06730100
To learn more about CBX-12, visit: https://www.cybrexa.com/